SeaCrest Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$229K Buy
2022
Q3
Sell
2022
Q2
$74K Buy
2021
Q4
Sell
2021
Q3
$1.03M Buy
2021
Q2
$235K Sell
2021
Q1
$208K Sell
2020
Q4
$570K Buy
2020
Q3
$282K Sell
2020
Q2
$655K Buy
2019
Q2
Sell
2019
Q1
$27K Buy
2018
Q4
$20K Sell
2018
Q3
$41K Sell
2018
Q2
$160K Buy
2018
Q1
$41K Buy